We are live on
!
Find out more
Apogee Therapeutics
APGE
APGE
139 hedge funds and large institutions have $3.52B invested in Apogee Therapeutics in 2024 Q1 according to their latest regulatory filings, with 62 funds opening new positions, 52 increasing their positions, 19 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
1,231% more call options, than puts
Call options by funds: $4.51M | Put options by funds: $339K
675% more first-time investments, than exits
New positions opened: 62 | Existing positions closed: 8
267% more funds holding in top 10
Funds holding in top 10: 3 → 11 (+8)
202% more capital invested
Capital invested by funds: $1.17B → $3.52B (+$2.35B)
174% more repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 19
64% more funds holding
Funds holding: 85 → 139 (+54)
7.93% more ownership
Funds ownership: 112.49% → 120.43% (+7.9%)
Holders
139
Holders Change
+54
Holders Change %
+63.53%
% of All Funds
2%
Holding in Top 10
11
Holding in Top 10 Change
+8
Holding in Top 10 Change %
+266.67%
% of All Funds
0.16%
New
62
Increased
52
Reduced
19
Closed
8
Calls
$4.51M
Puts
$339K
Net Calls
+$4.17M
Net Calls Change
+$4.17M
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$75.3M |
| 2 |
BlackRock
New York
|
+$50.9M |
| 3 |
B
Braidwell
Stamford,
Connecticut
|
+$50.7M |
| 4 |
State Street
Boston,
Massachusetts
|
+$42.3M |
| 5 |
DGM
Darwin Global Management
St. Helier,
Jersey
|
+$36.3M |
